Maribel Health, a company that helps healthcare systems design, build and operate technology-enabled home and community clinical care services, secured $25 million in a Series A funding round led by General Catalyst. The New Hampshire-based…
Continue Reading
What You Should Know:– Protai, a proteomics and AI-powered drug discovery startup revolutionizing the way new drugs are discovered, today announced a $12 million extension of its seed round, bringing the total amount to…
Continue Reading
Life sciences organizations have access to more data than ever before. When they leverage that existing data during their research and development (R&D) process, organizations can drive more efficient drug development.
Innovation and regulatory approval…
When you address a letter and send it in the mail, you can be fairly confident it will reach the right place and nowhere else. The same can’t be said for delivering drugs in…
Continue Reading
As we dive right into 2023, medical affairs teams are at a turning point.
MSLs are no longer wasting valuable time waiting in line within the halls of ivory towers, trying to get face-time or…
Chroma Medicine, a biotech company developing therapies that turn genes on or off as a way of treating genetic disorders, has raised $135 million as it works to generate data that could show the…
Continue Reading
CodaMetrix, an AI-powered platform for healthcare revenue cycle management, secured $55 million in Series A funding led by SignalFire. Yale Medicine, Frist Cressey Ventures, CU Healthcare Innovation Fund and Martin Ventures participated in the round….
Continue Reading
MorphoSys, a company whose research has yielded programs placed with big pharmaceutical companies and upstart biotechs, is stopping all preclinical work to focus on cancer, particularly a late-stage drug candidate it acquired in a…
Continue Reading
Multinational pharmaceutical and biotech company Pfizer and AI-powered data company Tempus announced a multi-year strategic alliance to utilize AI and machine learning to inform drug discovery and development in oncology. Pfizer will leverage Tempus’ library…
Continue Reading
What You Should Know:– Today, the AI-powered genetic testing and precision medicine company Tempus announced that it has signed a significant strategic agreement with Pfizer to more precisely gather insights that will inform novel drug discovery…
Continue Reading
